[Percutaneous treatment of coronary chronic total occlusions: state of the art]

Alessio Mattesini1, Serafina Valente1, Carlotta Sorini Dini1

  • 1SODc Cardiologia Interventistica Strutturale, AOU Careggi, Firenze.

Giornale Italiano Di Cardiologia (2006)
|June 28, 2017
PubMed

Insights

Percutaneous coronary intervention for chronic total occlusions (CTO) offers clinical benefits in select patients. Advanced techniques and specialized operators improve success rates, though CTO interventions remain complex.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) can yield favorable outcomes in specific patient groups.
  • Significant advancements in materials and strategies have improved CTO intervention success rates over recent decades.
  • CTO interventions continue to present challenges, with higher complication and lower success rates than standard PCI.

Purpose of the Study:

  • To present updated evidence on the clinical benefits of recanalizing chronic total occlusions.
  • To detail specialized interventional techniques for successful CTO recanalization.

Main Methods:

  • Review of current literature and interventional strategies for CTO PCI.
  • Analysis of clinical outcomes and complication rates associated with CTO interventions.

Main Results:

  • Successful CTO PCI is linked to positive clinical outcomes in carefully selected patients.
  • Dedicated interventional cardiologists specializing in CTO can achieve success rates approaching 90% with minimized complications.
  • Specialized techniques and materials are crucial for navigating complex CTOs.

Conclusions:

  • CTO recanalization is a valuable therapeutic option for selected patients, improving clinical outcomes.
  • The development of specialized techniques and the expertise of dedicated CTO operators are essential for optimizing success and safety.
  • Further advancements in interventional strategies are expected to enhance the efficacy of CTO PCI.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
433
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
366
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
516
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K